Clinical characteristics of BRASH syndrome: Systematic scoping review
- 5 June 2022
- journal article
- review article
- Published by Elsevier in European Journal of Internal Medicine
- Vol. 103, 57-61
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Reporting scoping reviews—PRISMA ScR extensionJournal of Clinical Epidemiology, 2020
- BRASH syndromeBMJ Case Reports, 2020
- Hyperkaliämie und BRASH-Syndrom in der NotfallmedizinNotfall + Rettungsmedizin, 2019
- BRASH SYNDROME: LOST IN PLAIN SIGHTChest, 2019
- SYNDROME OF BRADYCARDIA, RENAL FAILURE, ATRIOVENTRICULAR NODAL BLOCKERS, SHOCK, AND HYPERKALEMIA (BRASH SYNDROME): A NEW CLINICAL ENTITY?Chest, 2019
- PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and ExplanationAnnals of Internal Medicine, 2018
- Effects of calcium channel blockers comparing to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with hypertension and chronic kidney disease stage 3 to 5 and dialysis: A systematic review and meta-analysisPLOS ONE, 2017
- Safety and tolerability of beta-blockers: prejudices and realityEuropean Heart Journal Supplements, 2009
- Prognosis and Natural History of Drug-Related BradycardiaKorean Circulation Journal, 2009
- Prédiction du risque d’intolérance du traitement bêtabloquant chez l’insuffisant cardiaque chronique par le dosage du BNPAnnales de Cardiologie et d'Angéiologie, 2004